Jackson Thomas

Accepting PhD Students

If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Jackson Thomas (BPharm, MPharmSc, PhD) is a pharmacist, trialist, NHMRC-funded pharmaceutical scientist, and Associate Professor at the University of Canberra. Jackson also serves as a consultant for pharmaceutical manufacturers, biotech companies, and the Therapeutic Goods Administration (TGA). Prior to his appointment at UC in 2013, he held academic/research positions at University of Tasmania and Charles Darwin University (2004-2012).

Jackson has a specific clinical and research interest in indigenous child health, especially skin infections in Australian Indigenous children. Other research interests include (but are not limited to) global health (drug stability and counterfeit medications), dermatological conditions, discovery of bio-actives from natural resources, complementary and alternative medicine, and innovations in teaching. As a result of his research achievements, he was given the 2015 ACT Tall Poppy of the Year Award. Following on from this, he was selected into the Early- and Mid-Career Research Forum Executive Committee affiliated to Australian Academy of Science and a specialist advisor for Therapeutic Goods Administration (TGA).

Jackson's research group currently conducts pharmaceutical studies (including product formulation and stability trials), clinical and preclinical toxicological studies and animal and human clinical trials.

Jackson's recent contributions in the field of tropical infectious diseases have been recognised by several awards:

  • 2018: UC Finalist for the VC’s Early Career Researcher of the Year Award
  • 2018: UC Commendation for Distinction in Engagement
  • 2018: UC Research Excellence Award (ECR category)
  • 2017: Faculty of Health Research Impact Award
  • 2015: ARC nomination to represent Australia at Global Young Scientists Summit, Singapore
  • 2014: ACT Young Tall Poppy Award (Australian Institute of Policy & Science)

Related Links

Education/Academic qualification

PhD, University of Tasmania

… → 2010

External positions

Therapeutic Goods Administration, specialist Advisory Committee , Therapeutics Goods Administration

2017 → …

Appointed Executive Member Australian Academic of Science Early and Mid-Career Researcher (EMCR) Forum , Australian Academy of Science


Lecturer, Charles Darwin University


Research associate, University of Tasmania


Fingerprint Dive into the research topics where Jackson Thomas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Scabies Medicine & Life Sciences
Kunzea Medicine & Life Sciences
Dietary Supplements Medicine & Life Sciences
Pharmacists Medicine & Life Sciences
Onychomycosis Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences
Tea Tree Oil Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2022

Research Output 2009 2019

Antifungal drug use for onychomycosis

THOMAS, J., Peterson, G., Christenson, J. K., KOSARI, S. & Baby, K., May 2019, In : American Journal of Therapeutics. 26, 3, p. e388-e396 9 p.

Research output: Contribution to journalReview article

Pharmaceutical Preparations

Sand flea disease is neglected: what needs to be done

Bezabh, S., Peterson, G. M., THOMAS, J. & Heukelbach, J., 16 Jan 2019, The Conversation.

Research output: Contribution to Newspaper/Magazine/BulletinArticle

Open Access
Tunga penetrans
Latin America
skin diseases
2 Citations (Scopus)

An empirical review of antimalarial quality field surveys: the importance of characterising outcomes

Grech, J., Robertson, J., Thomas, J., Cooper, G., Naunton, M. & Kelly, T., 5 Jan 2018, In : Journal of Pharmaceutical and Biomedical Analysis. 147, p. 612-623 12 p.

Research output: Contribution to journalArticle

Sample Size
2 Citations (Scopus)
8 Downloads (Pure)

Are we doing enough to prevent poor-quality antimalarial medicines in the developing world?

Walker, E. J., Peterson, G. M., Grech, J., Paragalli, E. & Thomas, J., 15 May 2018, In : BMC Public Health. 18, 1, p. 1-6 6 p., 630.

Research output: Contribution to journalArticle

Open Access
Track and Field
Parasitic Diseases
Cost of Illness

Australian pharmacists' knowledge of the efficacy and safety of complementary medicines

Waddington, F., Naunton, M., Kyle, G., O'Kane, G., Cooper, G. & Thomas, J., 1 Jan 2018, In : Australian Journal of Primary Health. 24, 3, p. 273-279 7 p.

Research output: Contribution to journalArticle

Complementary Therapies
Social Media